Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Colorcon
Harvard Business School
Johnson and Johnson

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Patent: RE39941

See Plans and Pricing

« Back to Dashboard

Summary for Patent: RE39941
Title:Amelioration of Dupuytren\'s disease
Abstract: The cords of Dupuytren\'s disease are injected with collagenase, the hand is immediately immobilized and maintained immobile for several hours. The cord becomes relaxed or ruptured, relieving the hand contracture of the disease.
Inventor(s): Wegman; Thomas L. (N. Merrick, NY)
Assignee: Advance Biofactures Corporation (Lynbrook, NY)
Application Number:11/094,753
Patent Claims:see list of patent claims

Details for Patent RE39941

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Advance Biofactures Corporation (Lynbrook, NY) 2039-02-26 RX company
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Advance Biofactures Corporation (Lynbrook, NY) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Boehringer Ingelheim
Colorcon
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.